BEYONDSPRING INC (BYSI) Stock Price, Quote, News and Overview
NASDAQ:BYSI - Nasdaq - KYG108301006 - Common Stock - Currency: USD
BYSI Quote, Performance and Key Statistics
1.79
+0.07 (+4.07%)
The current stock price of BYSI is 1.79 USD. In the past month the price increased by 3.17%. In the past year, price increased by 64.22%.
BYSI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About BYSI
Company Profile
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in Florham Park, New Jersey and currently employs 36 full-time employees. The company went IPO on 2017-03-09. The firm is focused on developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs. The firm operates through two segments: the Plinabulin pipeline and Targeted Protein Degradation (TPD) platform. Plinabulin is being developed as a pipeline in a drug in various cancer indications as a direct anti-cancer agent and to prevent chemotherapy-induced neutropenia (CIN). Plinabulin is a small molecule derived from a natural compound found in marine microorganisms. The company is a selective immunomodulating microtubule-binding agent (SIMBA), which may provide multiple therapeutic opportunities. The TPD platform is utilizing molecular glue technology to develop therapeutic agents and discover and develop new chemical entities for the debilitating diseases and disorders. The firm is also developing three small-molecule immune agents.
Company Info
BEYONDSPRING INC
100 Campus Drive, West Side, 4Th Floor, Suite 410
Florham Park NEW JERSEY 10005 US
CEO: Lan Huang
Employees: 36
Company Website: https://www.beyondspringpharma.com/en/
Investor Relations: https://beyondspringpharma.com/stock-overview/
Phone: 16465284184
BEYONDSPRING INC / BYSI FAQ
What is the stock price of BEYONDSPRING INC today?
The current stock price of BYSI is 1.79 USD. The price increased by 4.07% in the last trading session.
What is the ticker symbol for BEYONDSPRING INC stock?
The exchange symbol of BEYONDSPRING INC is BYSI and it is listed on the Nasdaq exchange.
On which exchange is BYSI stock listed?
BYSI stock is listed on the Nasdaq exchange.
What is BEYONDSPRING INC worth?
BEYONDSPRING INC (BYSI) has a market capitalization of 72.14M USD. This makes BYSI a Micro Cap stock.
How many employees does BEYONDSPRING INC have?
BEYONDSPRING INC (BYSI) currently has 36 employees.
What are the support and resistance levels for BEYONDSPRING INC (BYSI) stock?
BEYONDSPRING INC (BYSI) has a support level at 1.73 and a resistance level at 1.8. Check the full technical report for a detailed analysis of BYSI support and resistance levels.
Should I buy BEYONDSPRING INC (BYSI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BYSI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BYSI, evaluating the profitability, health, valuation and growth aspects
- BEYONDSPRING INC (BYSI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BEYONDSPRING INC (BYSI) Sales and EPS estimates to see what analysts future expectations are.
- BEYONDSPRING INC (BYSI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BEYONDSPRING INC (BYSI) Insider and Institutional Ownership to learn about the owners and their transactions.
- BEYONDSPRING INC (BYSI) Stock Chart to make your own analysis
- BEYONDSPRING INC (BYSI) Latest news and press-releases to stay up to date.
Does BEYONDSPRING INC (BYSI) stock pay dividends?
BYSI does not pay a dividend.
What is the Price/Earnings (PE) ratio of BEYONDSPRING INC (BYSI)?
BEYONDSPRING INC (BYSI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
What is the Short Interest ratio of BEYONDSPRING INC (BYSI) stock?
The outstanding short interest for BEYONDSPRING INC (BYSI) is 6.52% of its float. Check the ownership tab for more information on the BYSI short interest.
BYSI Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BYSI. When comparing the yearly performance of all stocks, BYSI is one of the better performing stocks in the market, outperforming 91.33% of all stocks.
BYSI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BYSI. Both the profitability and financial health of BYSI have multiple concerns.
BYSI Financial Highlights
Over the last trailing twelve months BYSI reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS increased by 36.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -100.62% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BYSI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to BYSI. The Buy consensus is the average rating of analysts ratings from 7 analysts.